Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Bedossa

Showing results (221-230 of 267) with videos related to

Pageof 27
Sort By:
Histopathology|January 8, 2014
Pathology of the liver sinusoidsElizabeth M Brunt, Annette S H Gouw, Stefan G Hubscher, et al.
Scientific Reports|December 10, 2017
The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
The New England Journal of Medicine|June 25, 2023
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASHRohit Loomba, Arun J Sanyal, Kris V Kowdley, et al.
Gastroenterology|March 23, 2011
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis CJordi Bruix, Thierry Poynard, Massimo Colombo, et al.
Journal of Hepatology|September 29, 2011
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis CTarik Asselah, Simon De Muynck, Philippe Broët, et al.
Journal of Hepatology|June 5, 2016
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancerAmon Asgharpour, Sophie C Cazanave, Tommy Pacana, et al.
Gut|June 12, 2014
Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitisJef Verbeek, Matthias Lannoo, Eija Pirinen, et al.
Plos One|June 9, 2015
Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver AgreementBindia Jharap, Dirk P van Asseldonk, Nanne K H de Boer, et al.
The Lancet. Gastroenterology & Hepatology|October 6, 2023
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trialStephen A Harrison, Juan P Frias, Guy Neff, et al.
Gastroenterology|February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapyThierry Poynard, Massimo Colombo, Jordi Bruix, et al.
Pageof 27

Showing results (221-230 of 267) with videos related to

Sort By:
Pageof 27
Histopathology|January 8, 2014
Pathology of the liver sinusoidsElizabeth M Brunt, Annette S H Gouw, Stefan G Hubscher, et al.
Scientific Reports|December 10, 2017
The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver DiseaseSophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, et al.
The New England Journal of Medicine|June 25, 2023
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASHRohit Loomba, Arun J Sanyal, Kris V Kowdley, et al.
Gastroenterology|March 23, 2011
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis CJordi Bruix, Thierry Poynard, Massimo Colombo, et al.
Journal of Hepatology|September 29, 2011
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis CTarik Asselah, Simon De Muynck, Philippe Broët, et al.
Journal of Hepatology|June 5, 2016
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancerAmon Asgharpour, Sophie C Cazanave, Tommy Pacana, et al.
Gut|June 12, 2014
Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitisJef Verbeek, Matthias Lannoo, Eija Pirinen, et al.
Plos One|June 9, 2015
Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver AgreementBindia Jharap, Dirk P van Asseldonk, Nanne K H de Boer, et al.
The Lancet. Gastroenterology & Hepatology|October 6, 2023
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trialStephen A Harrison, Juan P Frias, Guy Neff, et al.
Gastroenterology|February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapyThierry Poynard, Massimo Colombo, Jordi Bruix, et al.
Pageof 27